Non-Hodgkin’s Lymphoma
Allynda Casterton
Science/162
October 24, 2012
Susan Avallone
NON-HODGKIN’S LYMPHOMA 2
Non-Hodgkin’s Lymphoma
Non-Hodgkin’s Lymphoma (NHL) is a cancer of the immune system. It is when abnormal white blood cells build up in the blood, bone marrow, spleen and / or the lymph nodes.
Researchers have found that people who have had a blood transfusion are at a higher risk of getting NHL. Even though transfusions cannot be avoided this must be discussed with your doctor. Researchers have also found that people who have taken an immune suppressant medication after an organ transplant or have under gone chemotherapy are at a higher risk of getting NHL. Immune suppressants are necessary to prevent the rejection of the new organ.
Genetic causes of cancer are to blame for less than 15% of the risks for cancer. Behavior is to blame for up to 60% and the rest is mainly the environment, like chemicals and air pollution. As for many cancers, including NHL, early detection or diagnosis does not affect the outcome of the disease.
There are 30 types of NHL. They are put into, two groups; Indolent NHL and Aggressive NHL. This is because of how fast they grow. Indolent NHL is a slow growing tumor, and the most common called follicular. NHL with follicular is a lifelong disease. There are many treatment options. This will help the patient live for many years. Intermediate and high grade or fat growing tumors called aggressive NHL. The most common type of aggressive NHL is diffuse large B-cell lymphoma (DLBCL). Aggressive NHL grows fast and for the best results, treatment needs to begin as soon as possible,
References: Biogen Idec Inc. Genentech, Inc. (2012). Rituxan and Non Hodgkin’s Lymphoma (NHL). This website is available at www.Rituxan.com. Accessed October 24, 2012. National Cancer Institute (2012). NCI website Non Hodgkin’s Lymphoma (NHL).This website is available at www.cancer.gov. Accessed October 25, 2012 .